Skip to menu Skip to content Skip to footer

2022

Conference Publication

Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia

Hardy, Todd, Aouad, Patrick, Blum, Stefan, Broadley, Simon, Carroll, William, Crimmins, Denis, Griffiths, Dayna, Hodgkinson, Suzanne, Lechner-Scott, Jeanette, Lee, Andrew, Malhotra, Ram, Parratt, John, Plummer, Chris, Walt, Anneke Van der and Walker, Robert (2022). Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia. ANZAN Annual Scientific Meeting 2022, Melbourne, VIC Australia, 10-13 May 2022. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2022-anzan.64

Novel generation of real-world evidence through MSGo, a digital support program supporting the use of siponimod in secondary progressive multiple sclerosis patients in Australia

2021

Conference Publication

Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic Phenomenon

Beer, Reuben, Shahid, Hassan, Brown, Helen and Blum, Stefan (2021). Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic Phenomenon. AAN 73rd Annual Meeting, Online, 17-22 April 2021. Ovid Technologies (Wolters Kluwer Health). doi: 10.1212/wnl.96.15_supplement.2975

Case Series: Two Cases of First Presentation AQP4-IgG Antibody Positive Neuromyelitis Optica in Patients of Advanced Age as a Possible Paraneoplastic Phenomenon

2020

Conference Publication

Real world safety of Alemtuzumab in the treatment of Multiple Sclerosis – Australian cohort study

Corbett, Joel, Blum, Stefan, Boggild, Mike, Broadley, Simon and McCombe, Pamela (2020). Real world safety of Alemtuzumab in the treatment of Multiple Sclerosis – Australian cohort study. 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.1499

Real world safety of Alemtuzumab in the treatment of Multiple Sclerosis – Australian cohort study

2020

Conference Publication

Generalised Epileptiform Activity in Anti-Glycine Receptor Antibody Autoimmune Limbic Encephalitis

Beer, Reuben, Singh, Gaurav, Blum, Stefan and Sabet, Arman (2020). Generalised Epileptiform Activity in Anti-Glycine Receptor Antibody Autoimmune Limbic Encephalitis. 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.2836

Generalised Epileptiform Activity in Anti-Glycine Receptor Antibody Autoimmune Limbic Encephalitis

2020

Conference Publication

Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888)

Warren, Nicola, O’Gorman, Cullen, Swayne, Andrew, Siskind, Dan and Blum, Stefan (2020). Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888). 2020 AAN Science Highlights, Online, 14 April 2020. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.94.15_supplement.4888

Specific Psychiatric Features Identify Anti-NMDAR Encephalitis Before Neurological Deterioration (4888)

2018

Conference Publication

Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes

Scott, James, Gillis, David, Ryan, Alex, Hargovan, Hethal and Blum, Stefan (2018). Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes. 6th Biennial Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 04-08 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby014

Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes

2018

Conference Publication

A case of immune-mediated encephalitis related to daclizumab therapy

Devlin, M., Swayne, A., O'Gorman, C., Newman, M., Brown, H., Robertson, T., Airey, C. and Blum, S. (2018). A case of immune-mediated encephalitis related to daclizumab therapy. 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Berlin, Germany, 10-12 October 2018. London, United Kingdom: Sage Publications.

A case of immune-mediated encephalitis related to daclizumab therapy

2018

Conference Publication

Psychiatric presentations of autoimmune encephalitis

Warren, N., Swayne, A. and Blum, S. (2018). Psychiatric presentations of autoimmune encephalitis. RANZCP 2018 Congress, Auckland, New Zealand, 13 – 17 May 2018. London, United Kingdom: Sage Publications.

Psychiatric presentations of autoimmune encephalitis

2018

Conference Publication

Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes

Scott, James, Gillis, David, Ryan, Alex, Hargovan, Hethal and Blum, Stefan (2018). Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes. 6th Biennial Schizophrenia International Research Society Conference, Florence, Italy, Apr 04 - 08, 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby014.157

Prevalence of anti-neuronal antibodies in patients admitted with first episode of psychosis and their clinical outcomes

2017

Conference Publication

Anti-nmda receptor encephalitis complicating hsv encephalitis with demonstrated seroconversion

Swayne, Andrew, Brown, Helen, Singh, Gaurav and Blum, Stefan (2017). Anti-nmda receptor encephalitis complicating hsv encephalitis with demonstrated seroconversion. ANZAN 2017, Gold Coast, QLD, Australia, 9 - 12 May 2017. London, United Kingdom: BMJ. doi: 10.1136/jnnp-2017-316074.82

Anti-nmda receptor encephalitis complicating hsv encephalitis with demonstrated seroconversion

2017

Conference Publication

Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial

Pender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial

2017

Conference Publication

Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis

Pender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications.

Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis

2017

Conference Publication

The many faces of anti-glycine receptor related disease: a case series and literature review

Swayne, Andrew, Tjoa, Linda, Wong, Richard, Gillis, David, Schweitzer, Daniel, Tsang, Benjamin, McNabb, Andrew, Broadley, Simon and Blum, Stefan (2017). The many faces of anti-glycine receptor related disease: a case series and literature review. Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), Gold Coast Australia, May 09-12, 2017. London, United Kingdom: BMJ Group. doi: 10.1136/jnnp-2017-316074.15

The many faces of anti-glycine receptor related disease: a case series and literature review

2017

Conference Publication

A rare case of csf xanthochromia due to severe disc protrusion resulting in froin’s syndrome

Singh, Gaurav, Swayne, Andrew, Blum, Stefan, Lehn, Alex, Brown, Helen and O’Gorman, Cullen (2017). A rare case of csf xanthochromia due to severe disc protrusion resulting in froin’s syndrome. ANZAN 2017, Gold Coast, QLD Australia, 9 - 12 May 2017. London, United Kingdom: BMJ. doi: 10.1136/jnnp-2017-316074.74

A rare case of csf xanthochromia due to severe disc protrusion resulting in froin’s syndrome

2016

Conference Publication

The prevalence of autoimmune encephalitis in patients presenting with first-episode psychosis

Scott, J. G., Gillis, D., Hargovan, H., Gundarpi, N., Ryan, A., Prain, K., Newman, M., Wong R, R., Parry, P. and Blum, S. (2016). The prevalence of autoimmune encephalitis in patients presenting with first-episode psychosis. RANZCP 2016 Congress, Hong Kong, 8-12 May 2016. London, United Kingdom: Sage Publications.

The prevalence of autoimmune encephalitis in patients presenting with first-episode psychosis

2014

Conference Publication

Cardiac effects of high-dose fingolimod ingestion

Sheikh, Nabeel, McCombe, Pamela and Blum, Stefan (2014). Cardiac effects of high-dose fingolimod ingestion. ANZAN Annual Scientific Meeting 2014, Adelaide, South Australia, Australia, May 2014. Elsevier. doi: 10.1016/j.jocn.2014.06.094

Cardiac effects of high-dose fingolimod ingestion

2014

Conference Publication

Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndrome

Blum, Stefan, Csurhes, Peter, Reddel, Stephen, Spies, Judy and McCombe, Pamela (2014). Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndrome. ANZAN Annual Scientific Meeting 2014, Adelaide, South Australia, Australia, May 2014. Elsevier. doi: 10.1016/j.jocn.2014.06.032

Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndrome

2014

Conference Publication

Characteristics of aquaporin 4 antibodies associated with lesions of the area postrema

Blum, Stefan, Prain, Kerri, Swayne, Andrew, Chong, Victor, Wong, Richard, Gillis, David and Wilson, Bob (2014). Characteristics of aquaporin 4 antibodies associated with lesions of the area postrema. ANZAN Annual Scientific Meeting 2014, Adelaide, South Australia, Australia, May 2014. Elsevier. doi: 10.1016/j.jocn.2014.06.023

Characteristics of aquaporin 4 antibodies associated with lesions of the area postrema

2012

Conference Publication

CT perfusion and bilateral paramedian thalamic stroke due to Artery of Percheron occlusion

Sheikh, N., Wong, A., O'Sullivan, J., Blum, S., Airey, C., Dionisio, S., Mitchell, K., Coulthard, A., Cloustan, J., Groundwater, A., Rajah, T., Jhamb, A. and Henderson, R. (2012). CT perfusion and bilateral paramedian thalamic stroke due to Artery of Percheron occlusion. Annual Scientific Meeting and the 8th Smart Strokes Australasian Nursing and Allied Health Stroke Conference, Sydney, NSW, Australia, 29-31 August 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1747-4930.2012.00907.x

CT perfusion and bilateral paramedian thalamic stroke due to Artery of Percheron occlusion

2010

Conference Publication

Clinical characteristics of Aquaporin 4 auto-antibody positive patients – A case series

Blum, Stefan, Wong, Richard, Gillis, David, Wilson, Bob, Prain, Kerryn and McCombe, Pamela (2010). Clinical characteristics of Aquaporin 4 auto-antibody positive patients – A case series. ANZAN Annual Scientific Meeting 2014, Adelaide, South Australia, Australia, May 2014. Elsevier. doi: 10.1016/j.jocn.2010.07.067

Clinical characteristics of Aquaporin 4 auto-antibody positive patients – A case series